Clinical Exploration Study of YOLT-203 in the Treatment of Type 1 Primary Hyperoxaluria (PH1)

NCT06511349 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Primary Hyperoxaluria

Interventions

DRUG: YOLT-203

Sponsor

RenJi Hospital